Wells Fargo downgraded Immune Design Corp. (Nasdaq: IMDZ) from an Outperform rating to a Market Perform rating sending the stock price tumbling $1.90 to close at $8.20.
Immune Design downgraded
October 17, 2017 at 18:40 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.